Author Page for Timo Minssen

Res Judicata in the ECJ Case Law: Balancing Legal Certainty with Legality?

European Constitutional Law Review, Issue 3, pp. 385-417, 2007

Number of pages: 33 Posted: 06 Oct 2009 Last Revised: 02 Sep 2015

Xavier Groussot and Timo Minssen

Lund University - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 847 (32,333)

Abstract:

2.

The Rule of Reason under Article 82 EC after Sot Lelos Kai Sia

Number of pages: 29 Posted: 07 Jul 2009 Last Revised: 02 Sep 2015

Tu T. Nguyen, Timo Minssen and Xavier Groussot

Faculty of Law, Lund University, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law

Downloads 681 (43,505)

Citation 1

Abstract:

3.

The Evolution of the CJEU's Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.

Published in Nordic Intellectual Property Law Review (NIR), Nr. 5, pp. 493-503 (2015).

Number of pages: 10 Posted: 13 Mar 2015 Last Revised: 25 Feb 2016

Timo Minssen and Ana Nordberg

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden

Downloads 676 (43,964)

Citation 4

Abstract:

4.

The Impact of Broccoli II & Tomato II on European Patents in Conventional Breeding, GMO's and Synthetic Biology: The Grand Finale of a Juicy Patents Tale?

Biotechnology Law Report, Vol. 34, No. 3 (2015), pp. 81-98

Number of pages: 24 Posted: 19 May 2015 Last Revised: 30 Jul 2017

Timo Minssen and Ana Nordberg

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden

Downloads 649 (46,421)

Citation 1

Abstract:

5.

Legal Aspects of Biobanking as Key Issues for Personalized Medicine & Translational Exploitation

Personalized Medicine, Vol. 11, No. 5, Pages 497-508

Number of pages: 16 Posted: 18 Jan 2014 Last Revised: 31 Dec 2014

Timo Minssen and Jens Schovsbo

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Information and Innovation Law (CIIR)

Downloads 376 (90,933)

Abstract:

6.

US Patent Eligibility in the Wake of Bilski v. Kappos: 'Business as Usual' in an Age of New Technologies?

Biotechnology Law Report, Vol. 30, Nr. 1, 2011, pp. 3-56, including a sequel at pp. 57-58.

Number of pages: 77 Posted: 26 Sep 2010 Last Revised: 01 Nov 2015

Timo Minssen and Robert M. Schwartz

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law

Downloads 369 (92,826)

Abstract:

7.

Patenting Bioprinting-Technologies in the US and Europe – The 5th Element in the 3rd Dimension

“Patenting Bioprinting Technologies in the US and Europe– The 5th element in the 3rd dimension". / Minssen, Timo; Mimler, Marc. 3D printing, Intellectual Property and Innovation – Insights from Law and Technology. ed. / Rosa Maria Ballardini; Marcus Norrgård; Jouni Partanen. Wolters Kluwer , 2017.

Number of pages: 27 Posted: 08 Apr 2017 Last Revised: 21 Jul 2020

Timo Minssen and Marc Mimler

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Bournemouth University - Centre for Intellectual Property Policy & Management (CIPPM)

Downloads 344 (100,879)

Citation 1

Abstract:

8.

Ethical and Legal Challenges of Artificial Intelligence-Driven Health Care

Forthcoming in: Artificial Intelligence in Healthcare, 1st edition, Adam Bohr, Kaveh Memarzadeh (eds.), ISBN: 9780128184387, Copyright Elsevier, 2020, Harvard Public Law Working Paper No. 20-35

Number of pages: 66 Posted: 26 May 2020 Last Revised: 10 Dec 2020

Sara Gerke, Timo Minssen and I. Glenn Cohen

Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Harvard Law School

Downloads 339 (102,590)

Citation 1

Abstract:

9.

Clinical Trial Data Transparency and GDPR Compliance: Implications for Data Sharing and Open Innovation

In: Katerina Sideri & Graham Dutfield (eds.), Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019 Forthcoming)

Number of pages: 19 Posted: 02 Jul 2019 Last Revised: 19 Jul 2019

Timo Minssen, Rajam Neethu and Marcel Bogers

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and University of Copenhagen - Department of Food and Resource Economics (IFRO)

Downloads 323 (107,913)

Citation 1

Abstract:

10.

The Industrial Application Requirement for Biotech Inventions in Light of Recent EPO & UK Case Law: A Plausible Approach or a Mere 'Hunting License'?

E.I.P.R. , Vol 34, Nr. 10, S. 689-703 (2012)

Number of pages: 23 Posted: 11 Sep 2014

Timo Minssen and David Nilsson

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Downloads 266 (133,166)

Abstract:

11.

Standardization, IPRs and Open Innovation in Synthetic Biology

Timo Minssen, and Jakob B. Wested. “Standardization, IPRs and Open Innovation in Synthetic Biology.” Innovation, Competition and Collaboration. Edward Elgar Publishing, 2015. 34–66. Web.

Number of pages: 20 Posted: 16 Feb 2014 Last Revised: 21 Jul 2020

Timo Minssen and Jakob Wested

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)

Downloads 245 (144,071)

Citation 3

Abstract:

12.

Meanwhile on the Other Side of the Pond: Why Biopharmaceutical Inventions that Were 'Obvious to Try' Still Might Be Non-Obvious – Part I

Chicago-Kent Journal of Intellectual Property, Vol. 9, Spring 2010

Number of pages: 72 Posted: 27 Sep 2009 Last Revised: 02 Sep 2015

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 243 (145,192)

Abstract:

13.

Research and Bolar Exemptions in the U.S. and Europe: Recent Developments and Possible Scenarios

Number of pages: 11 Posted: 30 Aug 2018

Jakob Wested and Timo Minssen

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 211 (166,130)

Abstract:

14.

Patenting Human Genes in Europe - And How It Compares to the US and Australia

Research Handbook on Intellectual Property and the Life Sciences (eds. Herbert Zech & Duncan Matthews), Chapter 1.5, Edward Elgar, 2016

Number of pages: 13 Posted: 27 Feb 2016 Last Revised: 29 Jul 2019

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 186 (186,622)

Abstract:

15.

A Review of 'Patents and Technological Progress in a Globalized World - Liber Amicorum Joseph Straus'

The IP Law Book Review, Vol. 2, Issue 2, January 2012

Number of pages: 12 Posted: 01 Sep 2011 Last Revised: 02 Sep 2015

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 174 (197,769)

Abstract:

16.

Restoring the Balance: The Patentability of DNA-Related Technology in the US and Europe

Number of pages: 10 Posted: 07 Oct 2009 Last Revised: 02 Sep 2015

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 149 (225,405)

Abstract:

17.

Book Review: Pharmaceutical Innovation, Competition and Patent Law – A Trilateral Perspective

Forthcoming in European Competition Law Review (E.C.L.R.). Issue 4, pp. 151-155 (Sweet & Maxwell 2014).

Number of pages: 6 Posted: 17 Feb 2014 Last Revised: 19 Feb 2014

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 135 (244,045)

Abstract:

18.

The 'Opt Out' and 'Opt-In' Provisions in the Unified Patent Court Agreement -- Impact and Strategies for European Patent Portfolios

Nordic Intellectual Property Law Review (NIR), Issue 4, pp 340-357 (2014)., University of Copenhagen Faculty of Law Research Paper No. 2015-3

Number of pages: 18 Posted: 22 Apr 2015 Last Revised: 08 Jul 2016

Timo Minssen and Bjorn Lundqvist

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Stockholm University - Faculty of Law

Downloads 121 (266,902)

Citation 1

Abstract:

19.

Rules and Tools in the Battle Against Superbugs - A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development

Forthcoming in Infectious Diseases in the New Millennium: Legal and Ethical Challenges, Mark Eccleston-Turner (ed) (Springer, June, 2020)., University of Copenhagen Faculty of Law Research Paper No. 2018-58

Number of pages: 23 Posted: 02 May 2018 Last Revised: 17 Mar 2020

Timo Minssen and Ana Nordberg

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Faculty of Law, Lund University, Sweden

Downloads 81 (345,657)

Abstract:

20.

Homomorphic Encryption: The ‘Holy Grail’ for Big Data Analytics & Legal Compliance in the Pharmaceutical and Healthcare Sector?

European Pharmaceutical Law Review (EPLR), 3(4):144-155

Number of pages: 14 Posted: 02 Dec 2019 Last Revised: 13 Nov 2020

Marcelo Corrales Compagnucci, Janos Meszaros, Timo Minssen, Arasaratnam Arasilango, Talal Ous and Muttukrishnan Rajarajan

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Academia Sinica - Institute of European and American Studies, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN

Downloads 77 (355,993)

Abstract:

21.

AIRR Data Under the E.U. Trade Secrets Directive: Aligning Scientific Practices with Commercial Realities

AIRR DATA UNDER THE E.U. TRADE SECRETS DIRECTIVE- ALIGNING SCIENTIFIC PRACTICES WITH COMMERCIAL REALITIES. / Sherkow, Jacob S.; Minssen, Timo. The harmonization and protection of trade secrets in the EU – An Appraisal of the EU Directive. ed. / Jens Schovsbo; Thomas Riis; Timo Minssen. Edward Elg, NYLS Legal Studies Research Paper No. 3249498

Number of pages: 23 Posted: 23 Oct 2018 Last Revised: 13 Jul 2020

Jacob S. Sherkow and Timo Minssen

University of Illinois College of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 74 (364,105)

Citation 1

Abstract:

22.

TRIPS and the Life Sciences - Perspectives on Limitations to Patentability

University of Copenhagen Faculty of Law Research Paper No. 2017-37

Number of pages: 9 Posted: 16 Jun 2017 Last Revised: 08 Jul 2017

Jakob Wested and Timo Minssen

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 69 (378,333)

Abstract:

23.

The US Examination of Nonobviousness after KSR vs. Teleflex with Special Emphasis on DNA-Related Inventions

IIC, Vol. 39, No. 8, pp. 886-916, 2008

Number of pages: 32 Posted: 13 Dec 2009 Last Revised: 02 Sep 2015

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 63 (396,811)

Abstract:

24.

Technology-Driven Disruption of Healthcare & 'UI Layer' Privacy-by-Design

Cambridge Bioethics and the Law series, Cambridge University Press, Forthcoming

Number of pages: 37 Posted: 22 Jun 2020 Last Revised: 09 Sep 2020

Marcelo Corrales Compagnucci, Mark Fenwick, Helena Haapio, Timo Minssen and Erik P.M. Vermeulen

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, Kyushu University - Graduate School of Law, University of Vaasa, School of Accounting and Finance, Business Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Tilburg Law School

Downloads 52 (434,543)

Abstract:

25.

Separating Sheep from Goats: A European View on the Patent Eligibility of Biomedical Diagnostic Methods

Journal of Law and the Biosciences, Vol. 3, No. 2, pp. 365-372 (2016)

Number of pages: 9 Posted: 27 Jun 2019

Timo Minssen and Robert M. Schwartz

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law

Downloads 44 (465,881)

Citation 1

Abstract:

26.

Procedural Aspects of Compulsory Licensing Under TRIPS: Report No. II of Webinar Series on Reinterpreting TRIPS in the Life Sciences

Number of pages: 9 Posted: 28 Sep 2017

Jakob Wested and Timo Minssen

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 40 (483,191)

Abstract:

27.

Patentability Standards for Follow-On Pharmaceutical Innovation

37 BIOTECHNOLOGY LAW REPORT 131 (2018)

Number of pages: 31 Posted: 31 Jul 2018 Last Revised: 06 May 2020

Christopher M. Holman, Timo Minssen and Eric M. Solovy

University of Missouri - Kansas City School of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Sidley Austin LLP

Downloads 26 (554,843)

Citation 1

Abstract:

28.

Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield

European Pharmaceutical Law Review (EPLR), 4(3):153-160

Number of pages: 11

Marcelo Corrales Compagnucci, Timo Minssen, Claudia Seitz and Mateo Aboy

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law and LML, University of Cambridge

Downloads 11

Abstract:

29.

Cutting Edges and Weaving Threads in the Gene Editing (Я)Evolution: Reconciling Scientific Progress with Legal, Ethical, & Social Concerns

Number of pages: 50 Posted: 14 Sep 2017 Last Revised: 17 Jul 2020

Ana Nordberg, Timo Minssen, Sune Holm, Maja Horst, Kell Mortensen and Birger Møller

Faculty of Law, Lund University, Sweden, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Department of Media, Cognition and Communication, University of Copenhagen - Department of Media, Cognition and Communication, Niels Bohr Institute, University of Copenhagen and University of Copenhagen - Centre for Synthetic Biology

Downloads 10 (662,912)

Abstract:

30.

Enforcing Patents in the Era of 3D Printing

Rosa Maria Ballardini, Marcus Norrgård, Timo Minssen, Enforcing patents in the era of 3D printing, Journal of Intellectual Property Law & Practice, Volume 10, Issue 11, November 2015, Pages 850–866, https://doi.org/10.1093/jiplp/jpv152

Number of pages: 17 Posted: 06 Dec 2015 Last Revised: 21 Jul 2020

Rosa Maria Ballardini, Marcus Norrgård and Timo Minssen

University of Helsinki - IPR University Center, University of Helsinki and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 10 (662,912)

Citation 3

Abstract:

31.

A ‘Ray of Hope’ for European Stem Cell Patents or ‘Out of the Smog into the Fog’?: An Analysis of Recent European Case Law and How It Compares to the US

IIC - International Review of Intellectual Property and Competition Law, 47(2), 138-177, Marh 2016, DOI: 10.1007/s40319-016-0449-x

Number of pages: 40 Posted: 27 Nov 2015 Last Revised: 21 Jul 2020

Ana Nordberg and Timo Minssen

Faculty of Law, Lund University, Sweden and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 10 (662,912)

Abstract:

32.

IPRs in Biobanking - Risks and Opportunities for Translational Research

Intellectual Property Quarterly, Vol. 2015, No.2, pp.106-129

Number of pages: 25 Posted: 27 Jun 2019 Last Revised: 21 Jul 2020

Timo Minssen, Michiel Verlinden and Isabelle Huys

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Research Centre for Pharmaceutical Care and Pharmaco-economics and affiliation not provided to SSRN

Downloads 8 (677,409)

Citation 2

Abstract:

33.

An Update on Research- & Bolar Exemptions in the U.S. and Europe: Unsolved Questions and New Developments in an Increasingly Important Area of Law

NIR: Nordiskt Immateriellt Rättsskydd, Vol. 2019, No. 2, pp. 168-183

Number of pages: 12 Posted: 25 Apr 2019 Last Revised: 16 Jul 2020

Jakob Wested and Timo Minssen

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 8 (677,409)

Abstract:

34.

Life after Myriad: The Uncertain Future of Patenting Biomedical Innovation & Personalized Medicine in an International Context

Intellectual Property Quarterly, Vol. 2015, Nr. 3, 08.2015, s. 189-241.

Number of pages: 59 Posted: 21 Jun 2015 Last Revised: 21 Jul 2020

Robert M. Schwartz and Timo Minssen

Lund University Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 6 (692,070)

Citation 1

Abstract:

35.

Reap What You Sow! — But What About SPC Squatting?

Journal of Intellectual Property Law & Practice, Vol. 13, No. 7, 2018, p. 569-580.

Number of pages: 12 Posted: 24 Apr 2019 Last Revised: 17 Jul 2020

Jens Schovsbo, Timo Minssen and Ulla Callesen Klinge

Centre for Information and Innovation Law (CIIR), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Inspicos P/S

Downloads 5 (699,347)

Abstract:

36.

Ten Simple Rules for a Successful Cross-Disciplinary Collaboration

Knapp B, Bardenet R, Bernabeu MO, Bordas R, Bruna M, Calderhead B, et al. (2015) Ten Simple Rules for a Successful Cross-Disciplinary Collaboration. PLoS Comput Biol 11(4): e1004214., DOI: 10.1371/journal.pcbi.1004214

Number of pages: 7 Posted: 28 Aug 2020

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 4 (706,818)

Abstract:

37.

När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa (When Does European Patent Law Regard a Biotechnological Invention As Complete and Having an Industrial Application?)

NIR : Nordiskt immateriellt rättsskydd, Vol. 77, No.4, pp. 339-387

Number of pages: 51 Posted: 28 Aug 2020

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 3 (714,873)

Abstract:

38.

Intellectual property rights, standards and data exchange in systems biology

Zimmeren, Esther, Berthold Rutz, and Timo Minssen. “Intellectual Property Rights, Standards and Data Exchange in Systems Biology.” Biotechnology Journal 11.12 (2016): 1477–1480. Web.

Number of pages: 6 Posted: 30 Jun 2019 Last Revised: 21 Jul 2020

Esther van Zimmeren, Berthold Rutz and Timo Minssen

University of Leuven, European Patent Office and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 3 (714,873)

Citation 1

Abstract:

39.

The US Supreme Court in Mayo v. Prometheus - Taking the Fire from or to Biotechnology and Personalized Medicine? Supreme Court of the United States, Mayo Collaborative Services, dba Mayo Medical Laboratories, et al., Petitioners v Prometheus Laboratories, Inc ., 132 S.Ct. 1289

Queen Mary Journal of Intellectual Property, Vol. 2, No. 4, pp.376-388 (2012)

Number of pages: 14 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020

Timo Minssen and David Nilsson

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Downloads 3 (714,873)

Citation 2

Abstract:

40.

Reconciling IPRs and Openness in Biobanking

European Intellectual Property Review, Vol. 38, No. 1, pp. 1-4, 2016

Number of pages: 6 Posted: 27 Jun 2019 Last Revised: 21 Jul 2020

Michiel Verlinden, Timo Minssen and Isabelle Huys

Research Centre for Pharmaceutical Care and Pharmaco-economics, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and affiliation not provided to SSRN

Downloads 2 (724,783)

Citation 1

Abstract:

41.

Unlocking the Full Potential of Open Innovation in the Life Sciences Through a Classification System

Drug Discovery Today, Vol. 23, No. 4, 01.04.2018, p. 771-775.

Number of pages: 6 Posted: 24 Apr 2019 Last Revised: 16 Jul 2020

Niclas Nilsson and Timo Minssen

affiliation not provided to SSRN and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 2 (724,783)

Abstract:

42.

Synthetic Biology and Intellectual Property Rights: Six Recommendations.

Minssen, Timo, Berthold Rutz, and Esther Van Zimmeren. “Synthetic Biology and Intellectual Property Rights: Six Recommendations.” Biotechnology Journal 10.2 (2015): 236–241. Web.

Number of pages: 7 Posted: 27 Feb 2016 Last Revised: 21 Jul 2020

Timo Minssen, Berthold Rutz and Esther van Zimmeren

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, European Patent Office and University of Leuven

Downloads 2 (724,783)

Citation 1

Abstract:

43.

Myriad Reloaded and Ready for the Next Round?

Queen Mary Journal of Intellectual Property, Vol.3, No.1, pp. 70-80 (2013)

Number of pages: 12 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020

Timo Minssen and Robert M. Schwartz

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law

Downloads 1 (736,963)

Abstract:

44.

Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross‐Disciplinary Perspective

Downloads 1 (736,963)

2

Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross‐Disciplinary Perspective

Bioethics, Vol. 34, Issue 1, pp. 16-32, 2020

Number of pages: 17 Posted: 01 May 2020

Ana Nordberg, Timo Minssen, Oliver Feeney, Iñigo de Miguel Beriain, Lucia Galvagni and Kirmo Wartiovaara

Faculty of Law, Lund University, Sweden, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Bioethical Research and Analysis (COBRA), National University of Ireland (Galway), Rep. of Ireland, affiliation not provided to SSRN, Independent and Independent

Downloads 1 (772,154)

Add to Cart

Abstract:

Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross-disciplinary Perspective

Posted: 10 Dec 2018 Last Revised: 15 Jan 2020

Ana Nordberg, Timo Minssen, Oliver Feeney, Iñigo de Miguel Beriain, Lucia Galvagni and Kirmo Wartiovaara

Faculty of Law, Lund University, Sweden, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Centre of Bioethical Research and Analysis (COBRA), National University of Ireland (Galway), Rep. of Ireland, Independent, Independent and Independent

Abstract:

45.

Challenges for the Sustainability of University-Run Biobanks

Downloads 1 (736,963)

Citation 1

1

Challenges for the Sustainability of University-Run Biobanks

Biopreservation and Biobanking, Vol. 16, No. 4, 08.2018, p. 312-321.

Number of pages: 29 Posted: 25 Apr 2019 Last Revised: 16 Jul 2020

Nana Cecilie Halmsted Kongsholm, Søren Tvorup Christensen, Janne Rothmar Herrmann, Lars Allan Larsen, Timo Minssen, Lotte Bang Pedersen, Rajam Neethu, Niels Tommerup, Aaro Tupasela and Jens Schovsbo

University of Copenhagen, University of Copenhagen, University of Copenhagen - Faculty of Law, University of Copenhagen, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen, University of Copenhagen, University of Copenhagen, University of Copenhagen and Centre for Information and Innovation Law (CIIR)

Downloads 1 (772,154)

Citation 1

Abstract:

46.

Standing on Shaky Ground - US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO: Part I

Queen Mary Journal of Intellectual Property Law, Vol. 1, No. 3, 2011

Number of pages: 26 Posted: 29 Sep 2011 Last Revised: 22 Jul 2020

Timo Minssen and David Nilsson

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Downloads 1 (736,963)

Abstract:

47.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics After AMP v. USPTO – Part IV

Standing on shaky ground- US patent-eligibility of isolated DNA and genetic diagnostics after AMP v. USPTO - Part IV. / Minssen, Timo; Schwartz, Robert M. In: Queen Mary Journal of Intellectual Property, Vol. 3, No. 2, 2013, p. 118-144.

Posted: 28 Oct 2020

Timo Minssen and Robert M. Schwartz

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University Faculty of Law

Abstract:

48.

Fighting Falsified Medicines with Paperwork – a Historic Review of Danish Legislation Governing Distribution of Medicines

Journal of Pharmaceutical Policy and Practice, Vol. 30, No. 9, 06.10.2016, p. 1-8., https://doi.org

Posted: 17 Oct 2020

Rasmus Borup and Timo Minssen

affiliation not provided to SSRN and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

49.

Innovation and Intellectual Property Policies in European Research Infrastructure Consortia — Part I: The Case of the European Spallation Source ERIC

Journal of Intellectual Property Law & Practice, Vol. 12, No. 5, 27.03.2017, p. 384–397. https://doi.org/10.1093/jiplp/jpx022

Posted: 17 Oct 2020

Helen Yu, Jakob Wested and Timo Minssen

University of Copenhagen - Center for Information and Innovation Law (CIIR), Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

50.

Will the EPO’s Enlarged Board of Appeal Hear the Broad's CRISPR Case?

In: Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018. https://www.lifesciencesipreview.com/article/will-the-epo-s-enlarged-board-hear-the-broad-s-crispr-case

Posted: 04 Sep 2020 Last Revised: 08 Sep 2020

Jakob Wested, Timo Minssen and Esther van Zimmeren

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Leuven

Abstract:

51.

The Legal Dimensions of Big Data, Artificial Intelligence and Machine Learning in Pharmaceutical Innovation (Original Title in Accepted Version): Editorial to Special Issue of the European Pharmaceutical Law Review on 'Big Data, AI & Machine Learning in Pharmaceutial Innovation'

Minssen, T. , & Seitz, C. Editorial European Pharmaceutical Law Review, Volume 3, Issue 4 (2019) pp. 139 - 141 DOI: 10.21552/eplr/2019/4/3

Posted: 18 Aug 2020

Timo Minssen and Claudia Seitz

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Ghent, Faculty of Law

Abstract:

52.

Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.

Posted: 18 Aug 2020

Mateo Aboy, Cristina Crespo, Kathleen Liddell, Timo Minssen and John Liddicoat

LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Cambridge - Faculty of Law

Abstract:

53.

Ethical and Legal Issues of Ingestible Electronic Sensors

Ethical and legal issues of ingestible electronic sensors. / Gerke, Sara; Minssen, Timo; Yu, Helen; Cohen, Glenn, Nature Electronics , Vol. 2, No. 8, 15.08.2019, p. 329–334.

Posted: 18 Aug 2020

Sara Gerke, Timo Minssen, Helen Yu and I. Glenn Cohen

Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Center for Information and Innovation Law (CIIR) and Harvard Law School

Abstract:

54.

One Year After Vanda, Are Diagnostics Patents Transforming Into Methods of Treatment to Overcome Mayo-Based Rejections?

One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections? / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen ; Davey, Neal; Liddicoat, Johnathan; Minssen, Timo., Nature Biotechnology, Vol. 38, 09.03.2020, p. 279–283.

Posted: 18 Aug 2020

Mateo Aboy, Cristina Crespo, Kathleen Liddell, Davey Neill, John Liddicoat and Timo Minssen

LML, University of Cambridge, University of Cambridge, University of Cambridge - Faculty of Law, affiliation not provided to SSRN, University of Cambridge - Faculty of Law and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

55.

How Does Emerging Patent Case Law in the US and Europe Affect Precision Medicine? How Will Today’s Patent Law Affect Tomorrow’s Innovation in the Areas of Biomarkers and Nature-Based Products; Diagnostics; and Algorithms, Big Data and AI?

Aboy, M., Liddell, K., Crespo, C. et al. How does emerging patent case law in the US and Europe affect precision medicine?. Nat Biotechnol 37, 1118–1125 (2019)

Posted: 18 Aug 2020

Mateo Aboy, I. Glenn Cohen, Kathleen Liddell, John Liddicoat, Cristina Crespo, Sara Gerke and Timo Minssen

LML, University of Cambridge, Harvard Law School, University of Cambridge - Faculty of Law, University of Cambridge - Faculty of Law, University of Cambridge, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

56.

Establishing the First International Genetic Discrimination Observatory

Joly, Y., Dalpé, G., Dupras, C. et al. Establishing the International Genetic Discrimination Observatory. Nat Genet 52, 466–468 (2020)

Posted: 18 Aug 2020

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

57.

An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014

An EU Comparative Analysis of the Regulation of Clinical Trials Supervisory Bodies in the Aftermath of Regulation 536/2014. de Miguel Beriain, Iñigo; Minssen, Timo; Chortara, Theodora; Duardo-Sánchez, Aliuska; Feeney, Oliver; Felzmann, Heike; Fernández de Uzquiano, Emma; Lievevrouw, Elisa

Posted: 14 Aug 2020

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

58.

The European Artificial Intelligence Strategy: Implications and Challenges for Digital Health

The European Artificial Intelligence Strategy: Implications and Challenges for Digital Health. / Cohen, Glenn ; Evgeniou, Theodoros; Gerke, Sara; Minssen, Timo, The Lancet Digital Health, Vol. 2, No. 7, 23.06.2020, p. 376-379

Posted: 14 Aug 2020

I. Glenn Cohen, Theodoros Evgeniou, Sara Gerke and Timo Minssen

Harvard Law School, INSEAD, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

59.

The EU-US Privacy Shield Regime for Cross- Border Transfers of Personal Data under the GDPR: What are the legal challenges and how might these affect cloudbased technologies, big data, and AI in the medical sector?

Lexxion, 2020

Posted: 14 Aug 2020

Timo Minssen, Claudia Seitz, Mateo Aboy and Marcelo Corrales Compagnucci

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Ghent, Faculty of Law, LML, University of Cambridge and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), Faculty of Law, University of Copenhagen

Abstract:

60.

Regulatory Responses to Medical Machine Learning

Regulatory responses to medical machine learning. / Minssen, Timo; Gerke, Sara; Aboy, Mateo; Price II, William Nicholson; Cohen, Glenn, 2020, Journal of Law and the Biosciences, Vol. 7, No. 1, 04.2020, p. 1-18. , DOI: 10.1093/jlb/lsaa002

Posted: 14 Aug 2020

Timo Minssen, Sara Gerke, Mateo Aboy, W. Nicholson Price II and I. Glenn Cohen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Harvard University - Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, LML, University of Cambridge, University of Michigan Law School and Harvard Law School

Abstract:

61.

When Does Stand-Alone Software Qualify As a Medical Device in the European Union? The CJEU Decision in SNITEM and What It Implies for the Next Generation of Medical Devices

When Does Stand-Alone Software Qualify As a Medical Device in the European Union? The CJEU decision in SNITEM and What It Implies for the Next Generation of Medical Devices. Minssen, Timo; Mimler, Marc; Mak, Vivian. In: Medical Law Review, Vol. 28, No. 3, 01.07.2020, p. 1-10

Posted: 14 Aug 2020

Timo Minssen, Marc Mimler and Vivian Mak

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Bournemouth University - Centre for Intellectual Property Policy & Management (CIPPM) and Vivian Mak Professional Services, Winchester, UK

Abstract:

62.

Germany's 2019 Digital Health Reforms in the Era of Covid-19: Lessons and Opportunities for Other Countries

npj Digital Medicine volume 3, Article number: 94 (2020)

Posted: 20 Jul 2020

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

63.

Big Data in the Health and Life Sciences: What Are the Challenges for European Competition Law and Where Can They Be Found?

CEIPI / ICTSD Publication Series on Global Perspectives and Challenges for the Intellectual Property System, 2018. p. 121-130.

Posted: 26 Aug 2019

Timo Minssen and Jens Schovsbo

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Centre for Information and Innovation Law (CIIR)

Abstract:

64.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after AMP v. USPTO – Part III (Unsolved Questions & Subsequent Case Law)

Queen Mary Journal of Intellectual Property, Vol. 2, No. 3, pp.225-249 (2012)

Number of pages: 26 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020

Timo Minssen and David Nilsson

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Downloads 0 (754,953)

Abstract:

65.

Standing on Shaky Ground- US Patent-Eligibility of Isolated DNA and Genetic Diagnostics after Amp v. Uspto – Part II (Practical Implications & Chances for Supreme Court Review)

Queen Mary Journal of Intellectual Property, Vol. 2, No. 2, pp.136-157 (2012)

Number of pages: 23 Posted: 27 Jun 2019 Last Revised: 22 Jul 2020

Timo Minssen and David Nilsson

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Independent

Downloads 0 (754,953)

Abstract:

66.

US Declatory Judgment Jurisdiction and the U.S. Supreme Court Decision InMedImmune (Zur Zulässigkeit von Feststellungsklagen im US Lizensrecht nach den Entscheidungen in MedImmune und SanDisk)

Gewerblicher Rechtsschutz und Urheberrecht. Internationaler Teil, Vol. 57, No.3, pp. 192-200, 2008

Posted: 27 Jun 2019

Timo Minssen and Gösta Schindler

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and affiliation not provided to SSRN

Abstract:

67.

Much Ado About Something: Legal, Ethical and Scientific Challenges in International Biobanking and Translational Exploitation

Global Genes, Local Concerns- Legal, Ethical and Scientific Challenges in International Biobanking.. ed. / Timo Minssen; Janne Rothmar Herrmann; Jens Schovsbo. Edward Elgar Publishing, 2019. ISBN 9781788116183

Posted: 26 Apr 2019

Timo Minssen, Janne Rothmar Herrmann and Jens Schovsbo

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen - Faculty of Law and Centre for Information and Innovation Law (CIIR)

Abstract:

68.

Clinical Trials Data Transparency & GDPR Compliance: What Are the Effects on Data Sharing and Open Innovation?

In : Katerina Sideri & Graham Dutfield (eds.), Openness, Intellectual Property and Science Policy in the Age of Data Driven Medicine, Special Issue of Science and Public Policy (2019)

Posted: 25 Apr 2019 Last Revised: 18 Jul 2019

Timo Minssen, Rajam Neethu and Marcel Bogers

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Copenhagen and University of Copenhagen - Department of Food and Resource Economics (IFRO)

Abstract:

69.

Shadow Health Records Meet New Data Privacy Laws

Science, Vol. 363, No. 6426, 01.02.2019, p. 448-450., U of Colorado Law Legal Studies Research Paper No. 19-13

Posted: 25 Apr 2019 Last Revised: 16 Jul 2020

W. Nicholson Price II, Kayte Spector-Bagdady, Timo Minssen and Margot E. Kaminski

University of Michigan Law School, University of Michigan at Ann Arbor - Medical School, University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Colorado Law School

Abstract:

70.

What Lurks in the Shadows of the Openness Hyperbole for Biopharmaceuticals?

What lurks in the shadows of the openness hyperbole for biopharmaceuticals? / Rajam, Neethu; Minssen, Timo. In: Drug Development Research, Vol. 80, No. 3, 11.05.2019, p. 282-284. https://doi.org/10.1002/ddr.21526

Posted: 25 Apr 2019 Last Revised: 06 Nov 2020

Rajam Neethu and Timo Minssen

University of Copenhagen and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Abstract:

71.

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Downloads 0 (754,953)

2

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol. 37, No. 1, 03.01.2019, p. 21-22.

Posted: 24 Apr 2019

Timo Minssen, Aaron S. Kesselheim and Jonathan J. Darrow

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

An 'Export-Only' Exception to Pharmaceutical Patents in Europe: Should the U.S. Follow Suit?

Nature Biotechnology, Vol.37, No. 1, pp. 21-22 (2019); DOI: 10.1038/nbt.4324

Posted: 27 Jun 2019

Timo Minssen, Aaron S. Kesselheim and Jonathan J. Darrow

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, Brigham and Women's Hospital/Harvard Medical School and Harvard Medical School

Abstract:

72.

Will the EPO’s Enlarged Board Hear the Broad’s CRISPR Case?

Life Sciences Intellectual Property Review (LSIPR), No. 13/7 2018, 13.07.2018.

Posted: 24 Apr 2019

Jakob Wested, Timo Minssen and Esther van Zimmeren

Centre for Advanced Studies in Biomedical Innovation Law (CeBIL), University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Leuven

Abstract:

73.

Clearing a Way Through the CRISPR Patent Jungle

Life Sciences Intellectual Property Review (LSIPR), No. 8/5 2018, 2018.

Posted: 24 Apr 2019

Timo Minssen, Esther van Zimmeren and Jakob Wested

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law, University of Leuven and Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)

Abstract:

74.

Big Data and Intellectual Property Rights in the Health and Life Sciences

Cambridge University Press, Big Data, Health Law, and Bioethics, 2018. p. 311-323.

Posted: 24 Apr 2019

Timo Minssen and Justin Pierce

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and Lund University - Faculty of Law

Abstract:

75.

A Ray of Light in Muddy Waters? -The CJEU Rules on Combination SPCs in C-121/17 Teva v Gilead

European Pharmaceutical Law Review, Vol. 2, No. 3, 2018, p. 169-173.

Posted: 24 Apr 2019

Timo Minssen and Sven Bostyn

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law and University of Liverpool - School of Law & Social Justice

Abstract:

76.

How Much Is Too Much?: Defining the Metes and Bounds of Excessive Pricing in the Pharmaceutical Sector

European Pharmaceutical Law Review Volume 2 (2018), Issue 3, Pages 133 - 148

Number of pages: 16 Posted: 16 Nov 2018 Last Revised: 09 Jan 2021

Behrang Kianzad and Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) and University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Downloads 0 (754,953)

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

Professor, Jur. Dr., LL.M., M.I.C.L.

76

Top 7,373

6,951

Top 28,982

24

5

Scholarly Papers (76)

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Regulating Germline Editing in Assisted Reproductive Technology: An EU Cross‐Disciplinary Perspective

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract:

Abstract: